InvestorsHub Logo
icon url

JUrology

01/23/17 1:02 PM

#49536 RE: SPORT19 #49534

Agree
icon url

Rebster

01/23/17 3:08 PM

#49539 RE: SPORT19 #49534

I had a discussion with a doctor whose practice uses the Da Vinci and he still questions the cost associated with its use in procedures. When I told him about Titans goal to make there surgical cost equivalent to standard lap he exclaimed " now that would be something!" He then asked me "whats the name of that company is again?"
icon url

Lurker05

01/24/17 12:25 AM

#49540 RE: SPORT19 #49534

Just a thought (been a while), but all we have is the suggested retail price or MSRP to go by. Totan could theoretically sell the units on a case by case basis for considerably less to fit the prospective client/hospitals ROI needs.

To your point, if its much more advanced than traditional laproscopy, and the price per procedure is even more in line, then thats a solid business case.

Then again, financing as well as us investors have to reevaluate what the market truly is based on a reduced revenue stream...